AHL
LAB icon

Abel Hall LLC’s Standard BioTools LAB Stock Holding History

Abel Hall LLC’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,503
Closed -$10.6K – 1027
2026
Q1 		$10.6K Buy
11,503
+276
+2% +$334 ﹤0.01% 802
2025
Q4 		$14.4K Sell
11,227
-143
-1% -$192 ﹤0.01% 707
2025
Q3 		$14.8K Buy
11,370
+185
+2% +$242 0.01% 318
2025
Q2 		$13.4K Buy
+11,185
New +$12.4K 0.01% 279

Other funds holding LAB

PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
VWA
VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Abel Hall LLC's LAB Position: Q2 2026 in Review

Abel Hall LLC sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 11,503 shares — an estimated $10.6K sold.

Abel Hall LLC first reported a position in LAB in Q2 2025 and held it in 4 quarters. The position peaked at $14.8K in Q3 2025. 16 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Abel Hall LLC reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
  • Abel Hall LLC sold 11,503 Standard BioTools shares in Q2 2026, an estimated $10.6K.
  • Abel Hall LLC first reported a position in Standard BioTools in Q2 2025 and held it in 4 quarters.
  • Abel Hall LLC's Standard BioTools position peaked at $14.8K in Q3 2025.
  • 16 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.